Bank7 Corp. Common stock (BSVN)

FairStock Score: 57/100 — STEADY

Key Financials

Strengths

• Solid return on equity of 18.6% above cost of capital
• Healthy net profit margin of 12.1% showing consistent profitability
• Attractive 2.6% dividend yield providing steady income returns

Concerns

• Revenue declining at 0.1% year-over-year signals potential demand weakness or market share loss
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
• Altman Z-Score of 0.3 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Bank7 Corp. Common stock is a micro-cap financial services company valued at $414 million. The business generates $99 million in annual revenue with a 12.1% net margin. From a quality standpoint, Bank7 shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 0.3 warrants caution. On valuation, the stock is deeply undervalued on a P/E basis at 9.0x, with a modest 18% margin of safety vs Graham Number. Growth dynamics show revenue growing at -0.1% and profit growth of -2.9%. The 2.6% dividend yield adds an income component for patient holders. Our composite FairStock Score of 57/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

The market underappreciates Bank7's consistent 19% ROE at just 9x earnings—a re-rating toward sector peers could unlock 30-50% upside. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the financial services space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer